Everything about Forex

Biotechnology company Allos Therapeutics Inc. asked the Food and Drug Administration to approve its cancer drug candidate pralatrexate, sending shares higher in afternoon trading.
Lesen hier die vollständige Nachricht

Kommentar schreiben

Name (required)

Mail (will not be published) (required)

Website

- UPDATE – HudBay operating results rise; NYSE listing planned (at Reuters)

- BMW in voller Beschleunigung

- US-Behörde brummt UBS Mio.-Busse auf

- [$$] Old Favorites Day (at TheStreet.com)

- Crush of mud finally plugs BP’s well in the Gulf

- Stocks rise on economic data